BMES spotlights biomedical engineering’s role in health, security and growth

The Biomedical Engineering Society is using the nation’s 250th anniversary to spotlight how biomedical engineering drives healthcare breakthroughs, national security tools and economic output. BMES also is promoting American Health Discovery, a new alliance aimed at raising public awareness of the field’s impact.

Why it matters: - Biomedical engineering now shapes diagnosis, treatment and prevention across modern medicine. - The field also supports national security, space exploration and U.S. economic growth. - BMES is trying to make a largely unseen industry more visible to the public.

What happened: - Biomedical Engineering Society featured biomedical engineering and BMES in America 250, a documentary series on USA Today tied to the United States’ 250th anniversary. - BMES launched American Health Discovery, a national alliance focused on celebrating biomedical engineering innovations and breakthroughs. - BMES directs readers to the campaign live here for the America 250 feature and to American Health Discovery for its new alliance.

The details: - Biomedical engineering has grown over five decades from a niche discipline into a core part of healthcare innovation. - The field helped produce implantable devices including pacemakers, artificial hearts, cochlear implants and joint replacements. - Biomedical engineering also enabled advances in 3D tissue printing, CRISPR-Cas9 gene editing and recombinant DNA technologies. - Those technologies support therapies for cancer, diabetes and other diseases. - Biomedical engineering contributes to biothreat detection systems and resilient supply chains through synthetic biology. - The field supports space missions with life-support systems and biomedical monitoring technologies. - Biomedical engineering contributes more than $69 billion annually to U.S. GDP. - The field supports millions of jobs and more than $36 billion in medical equipment exports. - Federal investment in biomedical innovation returns an estimated $2.56 for every dollar invested. - BMES was founded in 1968 and has served as a hub for multidisciplinary collaboration for nearly six decades. - BMES connects academia, industry, government and healthcare organizations. - BMES supports five communities: Cellular & Molecular Bioengineering, Advanced Biomanufacturing, Computational Biomedical Engineering, Medical Devices and Biomedical Engineering and Women’s Health. - BMES publishes four journals: Annals of Biomedical Engineering, Cellular and Molecular Bioengineering, Cardiovascular Engineering & Technology and Biomedical Engineering Education. - BMES says its members include pioneers who helped establish biomedical engineering as a distinct discipline and current global innovators.

Between the lines: - The BMES push pairs national-pride messaging with a policy and workforce argument: biomedical engineering is not just a research field, but an economic engine and strategic asset. - The American Health Discovery effort suggests BMES wants more public recognition for work that often happens out of sight in labs, hospitals, research centers and factories. - The 250th-anniversary backdrop gives the group a timely way to frame biomedical engineering as part of the American innovation story.

What's next: - BMES and its partners plan to use American Health Discovery to highlight the people, technologies and discoveries behind the field. - BMES will continue presenting biomedical engineering as central to health outcomes, domestic manufacturing and future innovation. - The society’s broader visibility push is likely to focus on reaching the public, not just researchers and industry insiders.

The bottom line: - BMES is positioning biomedical engineering as a pillar of U.S. health, security and competitiveness, while pushing for broader public recognition of its impact.